O'Reilly, KM; Mclaughlin AM, Beckett WS, Sime PJ (Março de 2007). «Asbestos-related lung disease». American Family Physician. 75 (5): 683–688. PMID17375514A referência emprega parâmetros obsoletos |coautor= (ajuda)
Collins, LG; Haines C, Perkel R, Enck RE (2007). «Lung cancer: diagnosis and management». American Academy of Family Physicians. American Family Physician. 75 (1): 56–63. PMID17225705A referência emprega parâmetros obsoletos |coautor= (ajuda)
Leroux, C; et al.; Girard N, Cottin V (março–abril de 2007). «Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep». Veterinary Research. 38 (2): 211–228. PMID17257570. doi:10.1051/vetres:2006060A referência emprega parâmetros obsoletos |coautor= (ajuda)
Zheng, H; et al.; Aziz HA, Nakanishi Y (2007). «Oncogenic role of JC virus in lung cancer». Journal of Pathology. 212 (3): 306–315. PMID17534844. doi:10.1002/path.2188A referência emprega parâmetros obsoletos |coautor= (ajuda)
Giuliani, L; et al.; Jaxmar T, Casadio C (2007). «Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma». Lung Cancer. 57 (3): 273–281. PMID17400331. doi:10.1016/j.lungcan.2007.02.019A referência emprega parâmetros obsoletos |coautor= (ajuda)
Krewski, D; Burnett R, Jerrett M, Pope CA, Rainham D, Calle E, Thurston G, Thun M (9–23 de julho de 2005). «Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort». J Toxicol Environ Health A. 68 (13–14): 1093–109. PMID16024490. doi:10.1080/15287390590935941A referência emprega parâmetros obsoletos |coautor= (ajuda)
Valavanidis, A; Fiotakis K, Vlachogianni T (Outubro–Dezembro de 2008). «Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms». J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 26 (4): 339–62. PMID19034792. doi:10.1080/10590500802494538A referência emprega parâmetros obsoletos |coautor= (ajuda)
Aviel-Ronen, S; Blackhall FH, Shepherd FA, Tsao MS (2006). «K-ras mutations in non-small-cell lung carcinoma: a review». Cancer Information Group. Clinical Lung Cancer. 8 (1): 30–38. PMID16870043. doi:10.3816/CLC.2006.n.030A referência emprega parâmetros obsoletos |coautor= (ajuda)
Devereux, TR; Taylor JA, Barrett JC (Março de 1996). «Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors». American College of Chest Physicians. Chest. 109 (Suppl 3): 14S–19S. PMID8598134. doi:10.1378/chest.109.3_Supplement.14SA referência emprega parâmetros obsoletos |coautor= (ajuda)
Subramanian, J; Govindan R (Fevereiro de 2007). «Lung cancer in never smokers: a review». American Society of Clinical Oncology. Journal of Clinical Oncology. 25 (5): 561–570. PMID17290066. doi:10.1200/JCO.2006.06.8015A referência emprega parâmetros obsoletos |coautor= (ajuda)
Raz, DJ; He B, Rosell R, Jablons DM (Março de 2006). «Bronchioloalveolar carcinoma: a review». Clinical Lung Cancer. 7 (5): 313–322. PMID16640802. doi:10.3816/CLC.2006.n.012A referência emprega parâmetros obsoletos |coautor= (ajuda)
Ferrell, B; Koczywas M, Grannis F, Harrington A (Abril de 2011). «Palliative care in lung cancer». Surgical Clinics of North America. 91 (2): 403–417. PMID21419260. doi:10.1016/j.suc.2010.12.003A referência emprega parâmetros obsoletos |coautor= (ajuda)
Odell, DD; Kent MS, Fernando HC (Primavera de 2010). «Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer». Seminars in Thoracic and Cardiovascular Surgery. 22 (1): 32–37. PMID20813314. doi:10.1053/j.semtcvs.2010.04.003A referência emprega parâmetros obsoletos |coautor= (ajuda)
Rueth, NM; Andrade RS (Junho de 2010). «Is VATS lobectomy better: perioperatively, biologically and oncologically?». Annals of Thoracic Surgery. 89 (6): S2107–S2111. PMID20493991. doi:10.1016/j.athoracsur.2010.03.020A referência emprega parâmetros obsoletos |coautor= (ajuda)
Goldstein, SD; Yang SC (Outubro de 2010). «Role of surgery in small cell lung cancer». Surgical Oncology Clinics of North America. 20 (4): 769–777. PMID21986271. doi:10.1016/j.soc.2011.08.001A referência emprega parâmetros obsoletos |coautor= (ajuda)
Hatton, MQ; Martin JE (Junho de 2010). «Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions». Clinical Oncology (Royal College of Radiologists). 22 (5): 356–364. PMID20399629. doi:10.1016/j.clon.2010.03.010A referência emprega parâmetros obsoletos |coautor= (ajuda)
Horn, L; Sandler AB, Putnam JB Jr, Johnson DH (2007). «The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer». Journal of Thoracic Oncology. 2 (5): 377–383. PMID17473651. doi:10.1097/01.JTO.0000268669.64625.bbA referência emprega parâmetros obsoletos |coautor= (ajuda)
Wakelee, HA; Schiller JH, Gandara DR (2006). «Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial». Cancer Information Group. Clinical Lung Cancer. 8 (1): 18–21. PMID16870041. doi:10.3816/CLC.2006.n.028A referência emprega parâmetros obsoletos |coautor= (ajuda)
Kelley, AS; Meier DE (Agosto de 2010). «Palliative care--a shifting paradigm». N. Engl. J. Med. 363 (8): 781–2. PMID20818881. doi:10.1056/NEJMe1004139A referência emprega parâmetros obsoletos |coautor= (ajuda)
Souquet, PJ; Chauvin F, Boissel JP, Bernard JP (Abril de 1995). «Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer». Lung Cancer. 12 Suppl 1: S147–54. PMID7551923. doi:10.1016/0169-5002(95)00430-9A referência emprega parâmetros obsoletos |coautor= (ajuda)
Burdett, Sarah, ed. (2010). Non-Small Cell Lung Cancer Collaborative Group. «Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer». Cochrane Database of Systematic Reviews (5). PMID20464750. doi:10.1002/14651858.CD007309.pub2. CD007309
Jemal, A; et al.; Tiwari RC, Murray T (2004). «Cancer statistics, 2004». CA Cancer J Clin. 54 (1): 8–29. PMID14974761. doi:10.3322/canjclin.54.1.8A referência emprega parâmetros obsoletos |coautor= (ajuda)
Proctor, RN (Março de 2012). «The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll». Tobacco Control. 21 (2): 87–91. PMID22345227. doi:10.1136/tobaccocontrol-2011-050338
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC14783544. OL24396062M, cited in Spiro SG, Silvestri GA (2005). «One hundred years of lung cancer». American Journal of Respiratory and Critical Care Medicine. 172 (5): 523–529. PMID15961694. doi:10.1164/rccm.200504-531OE
Saunders, M; et al.; Dische S, Barrett A (1997). «Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial». Elsevier. Lancet. 350 (9072): 161–165. PMID9250182. doi:10.1016/S0140-6736(97)06305-8A referência emprega parâmetros obsoletos |coautor= (ajuda)
Lennox, SC; et al.; Flavell G, Pollock DJ (1968). «Results of resection for oat-cell carcinoma of the lung». Elsevier. Lancet. 2 (7575): 925–927. PMID4176258. doi:10.1016/S0140-6736(68)91163-XA referência emprega parâmetros obsoletos |coautor= (ajuda)
Miller, AB; Fox W, Tall R (1969). «Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus». Elsevier. Lancet. 2 (7619): 501–505. PMID4184834. doi:10.1016/S0140-6736(69)90212-8A referência emprega parâmetros obsoletos |coautor= (ajuda)
There is sufficient evidence that involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) causes lung cancer in humans. [...] Involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) is carcinogenic to humans (Group 1).. «Tobacco Smoke and Involuntary Smoking»(PDF). WHO International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 83. 2002
O'Reilly, KM; Mclaughlin AM, Beckett WS, Sime PJ (Março de 2007). «Asbestos-related lung disease». American Family Physician. 75 (5): 683–688. PMID17375514A referência emprega parâmetros obsoletos |coautor= (ajuda)
Collins, LG; Haines C, Perkel R, Enck RE (2007). «Lung cancer: diagnosis and management». American Academy of Family Physicians. American Family Physician. 75 (1): 56–63. PMID17225705A referência emprega parâmetros obsoletos |coautor= (ajuda)
Jones, DR; Detterbeck FC (1998). «Pancoast tumors of the lung». Current Opinion in Pulmonary Medicine. 4 (4): 191–197. PMID10813231. doi:10.1097/00063198-199807000-00001A referência emprega parâmetros obsoletos |coautor= (ajuda)
Sopori, M (2002). «Effects of cigarette smoke on the immune system». Nature Reviews. Immunology. 2 (5): 372–7. PMID12033743. doi:10.1038/nri803
Samet, JM; Wiggins CL, Humble CG, Pathak DR (1988). «Cigarette smoking and lung cancer in New Mexico». American Review of Respiratory Disease. 137 (5): 1110–1113. PMID3264122A referência emprega parâmetros obsoletos |coautor= (ajuda)
Villeneuve, PJ; Mao Y (1994). «Lifetime probability of developing lung cancer, by smoking status, Canada». Canadian Journal of Public Health. 85 (6): 385–388. PMID7895211A referência emprega parâmetros obsoletos |coautor= (ajuda)
Leroux, C; et al.; Girard N, Cottin V (março–abril de 2007). «Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep». Veterinary Research. 38 (2): 211–228. PMID17257570. doi:10.1051/vetres:2006060A referência emprega parâmetros obsoletos |coautor= (ajuda)
Zheng, H; et al.; Aziz HA, Nakanishi Y (2007). «Oncogenic role of JC virus in lung cancer». Journal of Pathology. 212 (3): 306–315. PMID17534844. doi:10.1002/path.2188A referência emprega parâmetros obsoletos |coautor= (ajuda)
Giuliani, L; et al.; Jaxmar T, Casadio C (2007). «Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma». Lung Cancer. 57 (3): 273–281. PMID17400331. doi:10.1016/j.lungcan.2007.02.019A referência emprega parâmetros obsoletos |coautor= (ajuda)
Krewski, D; Burnett R, Jerrett M, Pope CA, Rainham D, Calle E, Thurston G, Thun M (9–23 de julho de 2005). «Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort». J Toxicol Environ Health A. 68 (13–14): 1093–109. PMID16024490. doi:10.1080/15287390590935941A referência emprega parâmetros obsoletos |coautor= (ajuda)
Valavanidis, A; Fiotakis K, Vlachogianni T (Outubro–Dezembro de 2008). «Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms». J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 26 (4): 339–62. PMID19034792. doi:10.1080/10590500802494538A referência emprega parâmetros obsoletos |coautor= (ajuda)
Aviel-Ronen, S; Blackhall FH, Shepherd FA, Tsao MS (2006). «K-ras mutations in non-small-cell lung carcinoma: a review». Cancer Information Group. Clinical Lung Cancer. 8 (1): 30–38. PMID16870043. doi:10.3816/CLC.2006.n.030A referência emprega parâmetros obsoletos |coautor= (ajuda)
Devereux, TR; Taylor JA, Barrett JC (Março de 1996). «Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors». American College of Chest Physicians. Chest. 109 (Suppl 3): 14S–19S. PMID8598134. doi:10.1378/chest.109.3_Supplement.14SA referência emprega parâmetros obsoletos |coautor= (ajuda)
Subramanian, J; Govindan R (Fevereiro de 2007). «Lung cancer in never smokers: a review». American Society of Clinical Oncology. Journal of Clinical Oncology. 25 (5): 561–570. PMID17290066. doi:10.1200/JCO.2006.06.8015A referência emprega parâmetros obsoletos |coautor= (ajuda)
Raz, DJ; He B, Rosell R, Jablons DM (Março de 2006). «Bronchioloalveolar carcinoma: a review». Clinical Lung Cancer. 7 (5): 313–322. PMID16640802. doi:10.3816/CLC.2006.n.012A referência emprega parâmetros obsoletos |coautor= (ajuda)
Ferrell, B; Koczywas M, Grannis F, Harrington A (Abril de 2011). «Palliative care in lung cancer». Surgical Clinics of North America. 91 (2): 403–417. PMID21419260. doi:10.1016/j.suc.2010.12.003A referência emprega parâmetros obsoletos |coautor= (ajuda)
Odell, DD; Kent MS, Fernando HC (Primavera de 2010). «Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer». Seminars in Thoracic and Cardiovascular Surgery. 22 (1): 32–37. PMID20813314. doi:10.1053/j.semtcvs.2010.04.003A referência emprega parâmetros obsoletos |coautor= (ajuda)
Goldstein, SD; Yang SC (Outubro de 2010). «Role of surgery in small cell lung cancer». Surgical Oncology Clinics of North America. 20 (4): 769–777. PMID21986271. doi:10.1016/j.soc.2011.08.001A referência emprega parâmetros obsoletos |coautor= (ajuda)
Hatton, MQ; Martin JE (Junho de 2010). «Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions». Clinical Oncology (Royal College of Radiologists). 22 (5): 356–364. PMID20399629. doi:10.1016/j.clon.2010.03.010A referência emprega parâmetros obsoletos |coautor= (ajuda)
Hann, CL; Rudin CM (30 de novembro de 2008). «Management of small-cell lung cancer: incremental changes but hope for the future». Oncology (Williston Park). 22 (13): 1486–92. PMID19133604A referência emprega parâmetros obsoletos |coautor= (ajuda)
Murray, N; Turrisi AT (Março de 2006). «A review of first-line treatment for small-cell lung cancer». Journal of Thoracic Oncology. 1 (3): 270–278. PMID17409868A referência emprega parâmetros obsoletos |coautor= (ajuda)
Azim, HA; Ganti AK (Março de 2007). «Treatment options for relapsed small-cell lung cancer». Anticancer drugs. 18 (3): 255–261. PMID17264756. doi:10.1097/CAD.0b013e328011a547A referência emprega parâmetros obsoletos |coautor= (ajuda)
Horn, L; Sandler AB, Putnam JB Jr, Johnson DH (2007). «The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer». Journal of Thoracic Oncology. 2 (5): 377–383. PMID17473651. doi:10.1097/01.JTO.0000268669.64625.bbA referência emprega parâmetros obsoletos |coautor= (ajuda)
Wakelee, HA; Schiller JH, Gandara DR (2006). «Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial». Cancer Information Group. Clinical Lung Cancer. 8 (1): 18–21. PMID16870041. doi:10.3816/CLC.2006.n.028A referência emprega parâmetros obsoletos |coautor= (ajuda)
Kelley, AS; Meier DE (Agosto de 2010). «Palliative care--a shifting paradigm». N. Engl. J. Med. 363 (8): 781–2. PMID20818881. doi:10.1056/NEJMe1004139A referência emprega parâmetros obsoletos |coautor= (ajuda)
Prince-Paul, M (Abril de 2009). «When hospice is the best option: an opportunity to redefine goals». Oncology (Williston Park, N.Y.). 23 (4 Suppl Nurse Ed): 13–7. PMID19856592
Souquet, PJ; Chauvin F, Boissel JP, Bernard JP (Abril de 1995). «Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer». Lung Cancer. 12 Suppl 1: S147–54. PMID7551923. doi:10.1016/0169-5002(95)00430-9A referência emprega parâmetros obsoletos |coautor= (ajuda)
Sörenson, S; Glimelius B, Nygren P (2001). «A systematic overview of chemotherapy effects in non-small cell lung cancer». Acta Oncol. 40 (2–3): 327–39. PMID11441939A referência emprega parâmetros obsoletos |coautor= (ajuda)
Clegg, A; Scott DA, Sidhu M, Hewitson P, Waugh N (2001). «A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer». Health Technol Assess. 5 (32): 1–195. PMID12065068A referência emprega parâmetros obsoletos |coautor= (ajuda)
Burdett, Sarah, ed. (2010). Non-Small Cell Lung Cancer Collaborative Group. «Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer». Cochrane Database of Systematic Reviews (5). PMID20464750. doi:10.1002/14651858.CD007309.pub2. CD007309
Jemal, A; et al.; Tiwari RC, Murray T (2004). «Cancer statistics, 2004». CA Cancer J Clin. 54 (1): 8–29. PMID14974761. doi:10.3322/canjclin.54.1.8A referência emprega parâmetros obsoletos |coautor= (ajuda)
Proctor, RN (Março de 2012). «The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll». Tobacco Control. 21 (2): 87–91. PMID22345227. doi:10.1136/tobaccocontrol-2011-050338
Kemp, FB (julho–setembro de 2009). «Smoke free policies in Europe. An overview». Pneumologia. 58 (3): 155–158. PMID19817310
Zhang, J; Ou JX, Bai CX (Novembro de 2011). «Tobacco smoking in China: prevalence, disease burden, challenges and future strategies». Respirology. 16 (8): 1165–1172. PMID21910781. doi:10.1111/j.1440-1843.2011.02062.xA referência emprega parâmetros obsoletos |coautor= (ajuda)
Behera, D; Balamugesh T (2004). «Lung cancer in India»(PDF). Indian Journal of Chest Diseases and Allied Sciences. 46 (4): 269–281. PMID15515828A referência emprega parâmetros obsoletos |coautor= (ajuda)
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC14783544. OL24396062M, cited in Spiro SG, Silvestri GA (2005). «One hundred years of lung cancer». American Journal of Respiratory and Critical Care Medicine. 172 (5): 523–529. PMID15961694. doi:10.1164/rccm.200504-531OE
Kabela, M (1956). «Erfahrungen mit der radikalen Röntgenbestrahlung des Bronchienkrebses» [Experience with radical irradiation of bronchial cancer]. Ceskoslovenská Onkológia (em alemão). 3 (2): 109–115. PMID13383622
Saunders, M; et al.; Dische S, Barrett A (1997). «Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial». Elsevier. Lancet. 350 (9072): 161–165. PMID9250182. doi:10.1016/S0140-6736(97)06305-8A referência emprega parâmetros obsoletos |coautor= (ajuda)
Lennox, SC; et al.; Flavell G, Pollock DJ (1968). «Results of resection for oat-cell carcinoma of the lung». Elsevier. Lancet. 2 (7575): 925–927. PMID4176258. doi:10.1016/S0140-6736(68)91163-XA referência emprega parâmetros obsoletos |coautor= (ajuda)
Miller, AB; Fox W, Tall R (1969). «Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus». Elsevier. Lancet. 2 (7619): 501–505. PMID4184834. doi:10.1016/S0140-6736(69)90212-8A referência emprega parâmetros obsoletos |coautor= (ajuda)
Cohen, M; et al.; Creaven PJ, Fossieck BE Jr (1977). «Intensive chemotherapy of small cell bronchogenic carcinoma». Cancer Treatment Reports. 61 (3): 349–354. PMID194691A referência emprega parâmetros obsoletos |coautor= (ajuda)
Morgagni, Giovanni Battista (1761). De sedibus et causis morborum per anatomen indagatis. [S.l.: s.n.] OL24830495M
Bayle, Gaspard-Laurent (1810). Recherches sur la phthisie pulmonaire (em francês). Paris: [s.n.] OL15355651W
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC14783544. OL24396062M, cited in Spiro SG, Silvestri GA (2005). «One hundred years of lung cancer». American Journal of Respiratory and Critical Care Medicine. 172 (5): 523–529. PMID15961694. doi:10.1164/rccm.200504-531OE
Behera, D; Balamugesh T (2004). «Lung cancer in India»(PDF). Indian Journal of Chest Diseases and Allied Sciences. 46 (4): 269–281. PMID15515828A referência emprega parâmetros obsoletos |coautor= (ajuda)
BMJ (2005). Clinical evidence concise : the international resource of the best available evidence for effective health care. London: BMJ Publishing Group. pp. 486–488. ISBN1-905545-00-2. ISSN1475-9225
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC14783544. OL24396062M, cited in Spiro SG, Silvestri GA (2005). «One hundred years of lung cancer». American Journal of Respiratory and Critical Care Medicine. 172 (5): 523–529. PMID15961694. doi:10.1164/rccm.200504-531OE